Search for: "Barr Laboratories IncĀ " Results 21 - 40 of 166
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Jul 2014, 12:54 pm
District Judge Tanya Walton Pratt concluded that Defendants Teva Parenteral Medicines, Inc. of Irvine, California; APP Pharmaceuticals, LLC of Schaumburg, Illinois; Pliva Hrvatska D.O.O. of Zagreb, Croatia; Teva Pharmaceuticals USA Inc. of North Wales, Pennsylvania; and Barr Laboratories, Inc. of Montvale, New Jersey failed to prove invalidity of U.S. [read post]
11 Jun 2014, 2:51 pm by Tom Lamb
Claimants allege that they have ­suffered personal injuries, some of them fatal, from the use of Bayer’s drospirenone-containing oral contraceptive products such as Yasmin™ and/or YAZ™ or from the use of Ocella™ and/or Gianvi™, generic versions of Yasmin™ and YAZ™, respectively, marketed by Barr Laboratories, Inc. in the United States. [read post]
25 Mar 2014, 9:59 pm by Patent Docs
Noonan -- In ANDA litigation between branded drug maker Alcon Research and generic drugmaker Barr Laboratories, the Federal Circuit affirmed a District Court finding of non-infringement and reversed a finding of invalidity for failure to satisfy either the enablement or written description requirements of 35 U.S.C. [read post]
20 Mar 2014, 5:34 pm
(“Alcon”) appeals from the final judgments of the United States District Court for the District of Delaware finding that Barr Laboratories, Inc. [read post]
30 Jul 2013, 2:58 pm by Todd Hanchett
Barr Laboratories, Inc. (9th Cir. 2009) (“That [plaintiff] later moved to reopen her bankruptcy proceedings does not excuse her earlier failure to disclose; judicial estoppel ensures that debtors make a ‘full and honest disclosure’ of their assets in the original bankruptcy proceeding. [read post]
4 Mar 2013, 2:20 pm by Tom Lamb
From the Yasmin™ / YAZ™ part of the Product-Related Litigation section of the drug company's most recent Annual Report, which was filed in late February 2013: Claimants allege that they have suffered personal injuries, some of them fatal, from the use of Bayer’s drospirenone-containing oral contraceptive products such as Yasmin™ and / or YAZ™ or from the use of Ocella™ and / or Gianvi™, generic versions of Yasmin™ and YAZ™,… [read post]
6 Feb 2013, 12:00 am
Barr Labs the Federal Circuit affirmed a decision by the District of Delaware finding that Barr Laboratories, Inc. and Sandoz Inc. had infringed a patent owned by Allergen, Inc., and finding the patent-in-suit valid. [read post]
30 Jan 2013, 8:22 am by Mandour & Associates
Barr Laboratories, Inc. and Sandoz, Inc. were found by the lower court to not have sufficiently proven their claims that Allergan’s patent was invalid due to prior art and obviousness. [read post]
26 Nov 2012, 2:35 pm by Tom Lamb
Claimants allege that they have suffered personal injuries, some of them fatal, from the use of Bayer’s drospirenone-containing oral contraceptive products such as Yasmin™ and/or YAZ™ or from the use of Ocella™ and/or Gianvi™, generic versions of Yasmin™ and YAZ™, respectively, marketed by Barr Laboratories, Inc. in the United States. [read post]
24 Aug 2012, 3:00 pm by Mandour & Associates
.'s patent for its chemotherapy treatment Alimta, rejecting a challenge from generic drug makers Teva Parenteral Medicines Inc., Barr Laboratories Inc. and APP Pharmaceuticals Inc. [read post]
24 Aug 2012, 2:57 pm
.'s patent for the chemotherapy drug pemetrexed, marketed under the name Alimta, is valid, overruling a challenge from generic pharmaceutical makers Teva Parenteral Medicines Inc., Barr Laboratories Inc. and APP Pharmaceuticals Inc. [read post]
22 Aug 2012, 3:02 am by FDABlog HPM
Court of Appeals for the District of Columbia Circuit laid out in In re Barr Laboratories, Inc., 930 F.2d 72 (D.C. [read post]
31 Jul 2012, 12:03 pm by Tom Lamb
  Claimants allege that they have suffered personal injuries, some of them fatal, from the use of Bayer’s drospirenone-containing oral contraceptive products such as Yasmin™ and / or YAZ™ or from the use of Ocella™ and / or Gianvi™, generic versions of Yasmin™ and YAZ™, respectively, marketed by Barr Laboratories, Inc. in the United States. [read post]
10 Apr 2012, 1:15 pm by Tom Lamb
  The Ocella and Gianvi birth control pills are from Teva Pharmaceuticals and Barr Laboratories; Zarah, a generic version of Yasmin, and Vestura, a generic version of YAZ. [read post]